PIK3CA and glioblastoma: The sample size of PIK3CA mutations was small; however, the mutation frequency in our large cohort was consistent with the findings of previous studies [15], and the demographic and molecular characteristics as well as treatment and outcomes in our entire cohort were largely comparable to those in other large published datasets on glioblastoma [17, 32], indicating the generalizability of our cohort.